Abbott Laboratories (ABT) Current Deferred Tax Assets (2009 - 2014)

Abbott Laboratories' Current Deferred Tax Assets history runs 6 years deep, the most recent figure standing at $1.7 billion for Q4 2014.

• In Q4 2014, Current Deferred Tax Assets fell 32.56% year-over-year to $1.7 billion; the TTM figure through Dec 2014 stood at $1.7 billion (down 32.56% YoY), while the FY2014 annual figure was $1.7 billion, down 32.56% from the prior year.
• Current Deferred Tax Assets came in at $1.7 billion for Q4 2014 at Abbott Laboratories, down from $2.5 billion in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $3.1 billion in Q4 2010 to a low of $1.7 billion in Q4 2014.
• A 5-year average of $2.6 billion and a median of $2.7 billion in 2011 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets soared 30.11% in 2010 and plunged 32.56% in 2014, its largest moves.
• Abbott Laboratories' Current Deferred Tax Assets stood at $3.1 billion in 2010, then declined by 12.19% to $2.7 billion in 2011, then grew by 10.55% to $3.0 billion in 2012, then declined by 15.34% to $2.5 billion in 2013, then slumped by 32.56% to $1.7 billion in 2014.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $1.7 billion, $2.5 billion, and $3.0 billion for Q4 2014, Q4 2013, and Q4 2012 respectively.

Peer Comparison